Involvement of Na+/Ca2+ exchanger in inside-out signaling through the platelet integrin α(IIb)β3

Blood

Volumn 92, Issue 10, 1998, Pages 3710-3720

  Shiraga, Masamichi ^b   Tomiyama, Yoshiaki ^a   Honda, Shigenori ^b   Suzuki, Hidenori ^b   Kosugi, Satoru ^b   Tadokoro, Seiji ^b   Kanakura, Yuzuru ^b   Tanoue, Kenjiro ^b   Kurata, Yoshiyuki ^b   Matsuzawa, Yuji ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3',4' DICHLOROBENZAMIL; ANTIPORTER; BEPRIDIL; CALCIMYCIN; CALCIUM ION; CHYMOTRYPSIN; FIBRINOGEN; INTEGRIN; MYOSIN LIGHT CHAIN; PADGEM PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLECKSTRIN; SEROTONIN; SODIUM ION; THROMBIN; 3',4'-DICHLOROBENZAMIL; AMILORIDE; CALCIUM; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; PHOSPHOPROTEIN; PLASMA PROTEIN; PLATELET PROTEIN P47; SODIUM; SODIUM CALCIUM EXCHANGE PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SODIUM CALCIUM EXCHANGE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; CELL GRANULE; DRUG ANTAGONISM; DRUG EFFECT; ION TRANSPORT; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SECRETION; SIGNAL TRANSDUCTION;

AMILORIDE; BEPRIDIL; BLOOD PLATELETS; BLOOD PROTEINS; CALCIMYCIN; CALCIUM; CHYMOTRYPSIN; CYTOPLASMIC GRANULES; FIBRINOGEN; HUMANS; ION TRANSPORT; MYOSIN LIGHT CHAINS; P-SELECTIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEROTONIN; SIGNAL TRANSDUCTION; SODIUM; SODIUM-CALCIUM EXCHANGER; TETRADECANOYLPHORBOL ACETATE;

EID: 0032532944     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3710.422k13_3710_3720     Document Type: Article

References (49)

1. Hynes RO: In te grins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
2. Rouslahti E: Integrins. J Clin Invest 87:1, 1991
3. Phillips DR, Charo IF, Parise LV, Fitzgerald LA: The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831, 1988
4. Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 332:1553, 1995
5. Smyth SS, Joneckis CC, Parise LV: Regulation of vascular integrins. Blood 81:2827, 1993
6. Faull RJ, Ginsberg MH: Dynamic regulation of integrins. Stem Cells 13:38, 1995
7. 3 integrins in hemostasis and vascular biology. Thromb Hemost 74:149, 1995
8. Shattil SJ, Hoxie JA, Cunningham M, Brass LF: Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 260:11107, 1985
9. Tomiyama Y, Tsubakio T, Piotrowicz RS, Kurata Y, Loftus JC, Kunicki TJ: The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood 79:2303, 1992
10. 3 integrin (platlelet GP IIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1:883, 1990
11. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 89:10169, 1992
12. 3- J Biol Chem 268:23087, 1993
13. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH: Integrin cytoplasmic domains mediate inside-out signal transduction. J Biol Chem 124:1047, 1994
14. Kroll MH, Schafer AI: Biochemical mechanisms of platelet activation. Blood 74:1181, 1989
15. Blockmans D, Dickmyn H, Vermylen J: Platelet activation. Blood Rev 9:143, 1995
16. Shattil SJ, Brass LF: Induction of the fibrinogen receptor on human platelets by imracellular mediators. J Biol Chem 262:992, 1987
17. 2+ and protein kinase C is the major factor in determining the level of secretion from human platelets. Biochem J 289:277, 1993
18. 2+ exchanger. Blood 88:2594, 1996
19. 2+ exchange in membrane vesicle and papillary muscle preparation from guinea pig heart by analogs of amiloride. Proc Natl Acad Sci USA 81:3238, 1984
20. Garcia ML, Slaughter RS, King VF, Kaczorowski GJ: Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicules. 2. Mechanism of inhibition by bepridil. Biochemistry 27:2410, 1988
21. Pulcinelli FM, Ashby B, Gazzaniga PP, Daniel JL: Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets. FEBS Lett 364:87, 1995
22. + exchanger block stimulus-provoked arachidonic acid release in human platelets. J Biol Chem 260:12910, 1985
23. 3 integrin). Thromb Haemost 76: 1038, 1996
24. McEver RP, Martin MN: A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 259:9799, 1984
25. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF: A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101:880, 1985
26. McConahey PJ, Dixon FJ: A method of trace iodination of proteins for immunologic studies. Int Arch Allergy 29:185, 1966
27. Suzuki H, Yamazaki H, Tanoue K: Immunocytochemical aspects of platelet membrane glycoproteins and adhesive proteins during activation. Prog Histochem Cytochem 30:1, 1996
28. 2+ exchanger of the human platelet. J Membr Biol 130:63, 1992
29. Yuan Y, Dopheide SM, Ivanidis C, Salem HH, Jackson SP: Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. J Biol Chem 272:21847, 1997
30. Willigen G, Akkerman JN: Regulation of glycoprotein IIB/IIIa exposure on platelets stimulated with α-thrombin. Blood 79:82, 1992
31. Gabbeta J, Yang X, Sun L, McLane MA, Niewiarowski S, Rao AK: Abnormal inside-out signal transduction-dependent Activation of glycoprotein IIb-IIIa in a patient with impaired plackstrin phosphorylation. Blood 87:1368, 1996
32. 3 subunit. J Cell Biol 131:807, 1995
33. 3 integrin cytoplasmic tail. J Cell Biol 137:1433, 1997
34. IIb cytoplasmic domain. J Biol Chem 272:4651, 1997
35. Greenberg JP, Packham MA, Guccione MA, Harfenist EJ, Orr JL, Kinlough-Rathbone RL, Perry DW, Mustard LF: The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood 54:753, 1979
36. Niewiarowski S, Budzynski AZ, Morinelli TA, Brudzynski TM, Stewart GJ: Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem 256:917, 1981
37. Suzuki H, Kinlough-Rathbone RL, Packham MA, Yamazaki H, Mustard JF: Association of fibrinogen with human platelets pretreated with chymotrypsin or aggregated with ADP or thrombin: an immunocy-tochemical study. Br J Exp Pathol 70:479, 1989
38. Brass LF, Hoxie JA, Manning DR: Signaling through G protein and G protein-coupled receptors during platelet activation. Thromb Haemost 70:217, 1993
39. + exchange. Biochem Biophys Res Commun 161:1228, 1989
40. + eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin. Proc Natl Acad Sci USA 80:5320, 1983
41. 2+ exchange. Eur J Pharmacol 105:317, 1984
42. 2+ exchange in plasma membrane vesicles. Thromb Haemost 57:337, 1987
43. 2+ exchanger of the human platelet. J Membr Biol 130:63, 1992
44. 2+ exchanger. Science 250:562, 1990
45. 2+ exchanger via protein kinase C. J Biol Chem 271:13609, 1996
46. 2+ transport in nerve fibers. Biochim Biophys Acta 947:549, 1988
47. Investigators TE: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956, 1994
48. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson DM, Lee KL, Willerson JT: Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 343:881, 1994
49. Higa S, Shimabukuro M, Shinzato T, Nagamine F, Murakami K, Takasu N: Long-term nifedipine treatment reduces calcium overload in isolated reperfused hearts of diabetic rats. Gen Pharmacol 26:1679, 1996